Press Releases
print

TechEmerge Brazil Selects 21 Innovators to Implement Pilots at Country’s Largest Healthcare Institutions


Press enquiries:
ADVICE Comunicação Corporativa

Christiane Mariotto –
christiane.mariotto@advicecc.com
Fernanda Dabori –
fernanda.dabori@advicecc.com
Tel.: (11) 5102-5258 / 5102-5252 / 99211-5097


Sao Paulo, December 14, 2018 - The TechEmerge Health Brazil program, organized by IFC, a member of the World Bank Group, in partnership with Bionexo, a technology company focused on healthcare management solutions, has just announced the 21 innovators from 7 countries selected to pilot their technology innovations in the Brazilian market with 16 healthcare providers. Pilots will receive support and grant funding under TechEmerge. The structured matchmaking program, which began last December and involved a major event in June, provided curated connections between technology companies from around the world and Brazilian healthcare institutions which jointly serve 19 million patients a year, including Hospital Israelita Albert Einstein, Fleury Group, Rede D'Or, Hospital Sírio-Libanês and Dasa Group.

The companies selected to partner with the healthcare institutions will now start to pilot innovative technologies that have significant potential to impact on healthcare delivery, including: fast and non-invasive diagnostic exams, artificial intelligence solutions for genetics and imaging diagnostics, population health management platforms, patient safety and many others.


“IFC is excited to help improve healthcare delivery and patient outcomes in Brazil through the TechEmerge program, with support from partners such as Bionexo. New technologies can significantly improve the lives of people, including through better access to quality care, said Iris de Graaf, Operations Officer at IFC. “The world is full of promising entrepreneurs developing innovative technology solutions. In IFC, we aim to connect these solutions with emerging economies to create markets that open up opportunities for all”, she added.


“After 11 months of intense work with IFC, we are proud to announce the companies that have been selected and will now have a unique opportunity to implement their technologies, backed by financial support from the program, building commercial partnerships with some of the top hospital institutions in Brazil - for many companies, this is their first contact with the Brazilian market”, explained Rodrigo Borer, CEO of Bionexo.


In addition to the financial support - provided by the governments of Israel and Finland in partnership with IFC – the awarded pilots, which are expected to start in December, will include technical oversight from Health 2.0, a consultancy firm that specializes in catalyzing digital health innovation around the world.


Selected companies that are awarded grant funding to implement pilot projects as part of TechEmerge Health Brazil (in alphabetical order):

Aidoc (USA)
Buddy Healthcare (Israel)

Chatr Health (USA)

CM Tecnologia (Brazil)

Combinostics Neuro (Finland)

Exalenz (Israel)

Hemaclear (Israel)

HFocus (Brazil)

Hi Technologies (Brazil)

Intuitive Care (Brazil)
Laura (Brazil)
Medicinia (Brazil)

Megical (Finland)

Nagis (Brazil)

Q Tracer (Netherlands)Sophia Genetics (Switzerland)

TNH Health (Brazil)

Transmural Biotech (Spain)

Twiage (USA)

Umanick (Spain)

Zebra (Israel)



For further information about TechEmerge Health Brazil, visit:
www.techemergebrazil.org  

About IFC

The IFC, a World Bank sister institution and member of the World Bank Group, is the world’s largest development institution focusing on the private sector in emerging markets. Working with over 2000 companies worldwide, we use our capital, expertise and influence to create markets and opportunities in some of the world’s toughest regions. During fiscal year 2018, our long-term investments in developing countries reached a record US$ 23 billion, leveraging the strength of the private sector to help bring an end to poverty and simulate shared prosperity. For further information, visit
www.ifc.org.

About Bionexo

Bionexo is a technology company offering digital solutions for healthcare process management. The Bionexo community includes more than 1,600 healthcare institutions and over 10,000 suppliers, generating over R$ 10 billion in annual transactions through its marketplace. Its digital products increase efficiency and transparency for 38% of private beds in Brazil and 64% of high complexity beds. The company sets the bar for building cloud-based digital solutions for healthcare and supporting industry innovation, making a decisive contribution to a more professional and digital healthcare sector in Brazil and the other countries where it operates: Argentina Colombia, Mexico and Spain.


Follow Bionexo on social media:
LinkedIn, Facebook and YouTube.